Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients

Purpose: To assess the frequency of mutations in the Myocilin (MYOC) gene in Iranian patients affected with primary congenital glaucoma (PCG). Methods: The individuals evaluated herein are among a larger cohort of 100 patients who had previously been screened for CYP1B1 mutations. Eighty subjects c...

Full description

Bibliographic Details
Main Authors: Elahe Elahi, Mehrnaz Narooie-Nejhad, Fatemeh Suri, Shahin Yazdani
Format: Article
Language:English
Published: Knowledge E 2010-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2010;volume=5;issue=2;spage=101;epage=104;aulast=Elahi
_version_ 1811332593464901632
author Elahe Elahi
Mehrnaz Narooie-Nejhad
Fatemeh Suri
Shahin Yazdani
author_facet Elahe Elahi
Mehrnaz Narooie-Nejhad
Fatemeh Suri
Shahin Yazdani
author_sort Elahe Elahi
collection DOAJ
description Purpose: To assess the frequency of mutations in the Myocilin (MYOC) gene in Iranian patients affected with primary congenital glaucoma (PCG). Methods: The individuals evaluated herein are among a larger cohort of 100 patients who had previously been screened for CYP1B1 mutations. Eighty subjects carried mutations in CYP1B1, but the remaining 20 patients who did not, underwent screening for MYOC mutations for the purpose of the study. MYOC exons in the DNA were polymerase chain reaction (PCR) amplified and sequenced. Sequencing was performed using PCR primers, the ABI big dye chemistry and an ABI3730XL instrument. Sequences were analyzed by comparing them to reference MYOC sequences using the Sequencher software. Results: Four MYOC sequence variations were observed among the patients, but none of them were considered to be associated with disease status. Three of these variations were single nucleotide polymorphisms already reported not to be disease causing, the fourth variation created a synonymous codon and did not affect any amino acid change. Conclusion: In this cohort, MYOC mutations were not observed in any Iranian subject with PCG. It is possible that in a larger sample, a few subjects carrying disease causing MYOC mutations could have been observed. But our results show that the contribution of MYOC to PCG status in Iran is small if any.
first_indexed 2024-04-13T16:39:07Z
format Article
id doaj.art-a0904e7b038e4cf78dac4ef90414c6ee
institution Directory Open Access Journal
issn 2008-322X
language English
last_indexed 2024-04-13T16:39:07Z
publishDate 2010-01-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj.art-a0904e7b038e4cf78dac4ef90414c6ee2022-12-22T02:39:19ZengKnowledge EJournal of Ophthalmic & Vision Research2008-322X2010-01-0152101104Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian PatientsElahe ElahiMehrnaz Narooie-NejhadFatemeh SuriShahin YazdaniPurpose: To assess the frequency of mutations in the Myocilin (MYOC) gene in Iranian patients affected with primary congenital glaucoma (PCG). Methods: The individuals evaluated herein are among a larger cohort of 100 patients who had previously been screened for CYP1B1 mutations. Eighty subjects carried mutations in CYP1B1, but the remaining 20 patients who did not, underwent screening for MYOC mutations for the purpose of the study. MYOC exons in the DNA were polymerase chain reaction (PCR) amplified and sequenced. Sequencing was performed using PCR primers, the ABI big dye chemistry and an ABI3730XL instrument. Sequences were analyzed by comparing them to reference MYOC sequences using the Sequencher software. Results: Four MYOC sequence variations were observed among the patients, but none of them were considered to be associated with disease status. Three of these variations were single nucleotide polymorphisms already reported not to be disease causing, the fourth variation created a synonymous codon and did not affect any amino acid change. Conclusion: In this cohort, MYOC mutations were not observed in any Iranian subject with PCG. It is possible that in a larger sample, a few subjects carrying disease causing MYOC mutations could have been observed. But our results show that the contribution of MYOC to PCG status in Iran is small if any.http://www.jovr.org/article.asp?issn=2008-322X;year=2010;volume=5;issue=2;spage=101;epage=104;aulast=ElahiPrimary Congenital Glaucoma; Myocilin
spellingShingle Elahe Elahi
Mehrnaz Narooie-Nejhad
Fatemeh Suri
Shahin Yazdani
Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
Journal of Ophthalmic & Vision Research
Primary Congenital Glaucoma; Myocilin
title Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
title_full Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
title_fullStr Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
title_full_unstemmed Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
title_short Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
title_sort myocilin mutations are not a major cause of primary congenital glaucoma in iranian patients
topic Primary Congenital Glaucoma; Myocilin
url http://www.jovr.org/article.asp?issn=2008-322X;year=2010;volume=5;issue=2;spage=101;epage=104;aulast=Elahi
work_keys_str_mv AT elaheelahi myocilinmutationsarenotamajorcauseofprimarycongenitalglaucomainiranianpatients
AT mehrnaznarooienejhad myocilinmutationsarenotamajorcauseofprimarycongenitalglaucomainiranianpatients
AT fatemehsuri myocilinmutationsarenotamajorcauseofprimarycongenitalglaucomainiranianpatients
AT shahinyazdani myocilinmutationsarenotamajorcauseofprimarycongenitalglaucomainiranianpatients